Hematology

Filter

nicola conran

Quickfire Q&A: Nicola Conran

July 2026

Nicola Conran shares insights from EHA 2026 on emerging therapies, gene editing, inflammation, and the evolving treatment landscape in sickle cell disease.

nicola conran

Quickfire Q&A: Nicola Conran

Nicola Conran shares insights from EHA 2026 on emerging therapies, gene editing, inflammation, and the evolving treatment landscape in sickle cell disease.

Improved Outcomes in Lower-Risk MDS

This lower-risk myelodysplastic syndromes symposium provided an overview of emerging data from pivotal trials and real-world evidence…

Optimizing IDH1m Treatment in AML

This symposium from European Hematology Association (EHA) 2026 in Stockholm, Sweden, chaired by Gail Roboz, will explore three key…

Our Latest EMJ Hematology Journal

Care in this field is transforming rapidly. To optimise patient outcomes and navigate evolving treatment pathways, clinicians need a clear…

Quickfire Q&A: Roberto Mina

Roberto Mina shares insights from EHA 2026 on MonumenTAL-3, MajesTEC-9, CEPHEUS, and the evolving multiple myeloma treatment landscape.

EHA Congress Wrap

The European Hematology Association (EHA) Congress 2026 brought together haematology experts from around the world to share the latest…

R/R DLBCL in 2026: Gaps and Next Moves

This Sobi symposium, recorded live at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden, brings…

Multi-Immune Modulation in ITP and wAIHA

This symposium explores the evolving understanding of immune dysregulation in immune thrombocytopenia (ITP) and warm antibody…

Loading posts...

1 2 3 … 11 Next »